Global Clinical Trial Market Analysed in New Comprehensive Report Now Available at MarketPublishers.com

19 Sep 2011 • by Natalie Aster
Global Clinical Trial Market Analysed in New Comprehensive Report Now Available at MarketPublishers.com

LONDON – Clinical trials market is spreading further to the east. New opportunities and development avenues are opening up in the developing nations. Major pharmaceutical companies are directing their investment flows in these countries where the regulations and R&D projects seem to be more beneficial for marketers.

The largest share of the phase II/III (prime stages) clinical trials conducted across the globe belongs to the developing nations. The focus here relies on oncology, Alzheimer’s, metabolic and cardiovascular diseases. One of the key factors that impacts the clinical trials market here is the extensive support provided by the respective government bodies.

New market research report Global Clinical Trial Market (2007 - 2010) (Key Therapeutic Categories, Country Wise Metrics & Regulatory Approval Framework)developed by MarketsandMarkets delivers a deep insight into the global clinical trial market. The market here is categorized on the basis of phases and indications. The study provides a detailed analysis of the trends in each. Market data, drivers, trends and opportunities, key players and their profiles, and competitive outlook is featured in the realm of the study.

Report Details:

Title: Global Clinical Trial Market (2007 - 2010) (Key Therapeutic Categories, Country Wise Metrics & Regulatory Approval Framework)
Published: September, 2011
Pages: 281
Price: US$ 4,650

Report Contents:

1 INTRODUCTION
1.1 Key Take-aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology

2 EXECUTIVE SUMMARY
2.1 Overview of the Market
2.2 Key Findings


3 MARKET OVERVIEW
3.1 Market Definition
3.2 Drivers
  3.2.1 Globalizing drug development activities
  3.2.2 Rise in r&d investments expected to boost the clinical trials market
  3.2.3 High disease prevalence in emerging countries
3.3 Restraints
  3.3.1 Longer approval time for clinical trials – a cause of concern for major pharmaceutical-biotechnology players
3.4 Burning Issues
  3.4.1 Out skirting boundaries of medical ethics
3.5 Winning Imperatives
  3.5.1 Leveraging online resources to increase patient recruitment rates in clinical trials
3.6 Country Comparison
3.7 Industry Trends

To order the report or ask for free sample pages, please contact ps@marketpublishers.com

 

CONTACTS

The Market Publishers, Ltd.

Tanya Rezler

Tel: +44 208 144 6009

Fax: +44 207 900 3970

ps@marketpublishers.com

www.marketpublishers.com